Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine
about
Vaccines for preventing rotavirus diarrhoea: vaccines in useVaccines for preventing rotavirus diarrhoea: vaccines in useOral immunoglobulin for the prevention of rotavirus infection in low birth weight infantsVaccines for preventing rotavirus diarrhoea: vaccines in useOral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infantsOral ondansetron administration in emergency departments to children with gastroenteritis: an economic analysisIs rotavirus still a major cause for diarrheal illness in hospitalized pediatric patients after rotavirus vaccine introduction in the Saudi national immunization program?Recommendations for the use of rotavirus vaccines in infantsPrevention and treatment of viral diarrhea in pediatrics.Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination.Positive Family History, Infection, Low Absolute Lymphocyte Count (ALC), and Absent Thymic Shadow: Diagnostic Clues for All Molecular Forms of Severe Combined Immunodeficiency (SCID).Public Health Impact of Complete and Incomplete Rotavirus Vaccination among Commercially and Medicaid Insured Children in the United States.Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs.Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in developed countries.Laboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination.Acute infectious diarrhea in children.A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix.Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine.Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries.Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.Early observations in the use of oral rotavirus vaccination in infants with functional short gut syndrome.Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in the prevention of rotavirus gastroenteritis in developing countries.Impact on rotavirus gastro-enteritis hospitalisation during the first year of universal vaccination in Sicily.Treatment and prevention of rotavirus infection in children.Viral gastroenteritis in Charleston, West Virginia, in 2007: from birth to 99 years of age.Des recommandations quant à l’usage des vaccins antirotavirus chez les nourrissons.Rotavirus vaccination can be performed without viral dissemination in the Neonatal Intensive Care Unit.Perspectives and attitudes of pediatricians concerning post-discharge care practice of premature infants.
P2860
Q24197495-5A163CB6-48CA-4975-B90A-C4B78110CA41Q24203645-8D4E63FC-E9B7-449B-AC61-5CA676DE5595Q24235408-C73ACF87-7D70-4BBF-AEC7-8A5AA835B1F7Q24235411-936BE4B0-E0F2-430F-B75F-16AA7CD1191FQ24236023-230F51DB-67B3-44CD-83D0-183467725E4CQ28475751-19720144-8F94-4ED5-BC6D-06B32A9A60ABQ33597262-A6B9AB11-431A-4270-A7B7-EDBA8EB0CFB0Q34187771-BC069336-DAF7-493E-B718-00DD4F10F0A0Q34616273-5EA5574E-6EFF-47C3-9F38-BD29D655FF5EQ34690736-910D42B8-29F1-4657-9F5D-D71BCF78C130Q35846963-E2B43DE2-31B1-4370-9D3F-2C68999597A4Q35889946-35919477-BADC-4C39-9091-4AD07ADBFCD1Q36201298-0BF4B1DE-DB18-4D8E-9689-6D14C2A1E5C8Q36650016-38EE3A10-E92E-43D5-8DD7-0BD91932B0EDQ36851125-ED665016-6748-47F6-9316-EEE67EC45C72Q37332138-7824FEA2-A628-4F56-B3CC-6A0A712CC036Q37547272-8D48443F-604E-4F27-8F4E-5198B32832A7Q37857326-521E10A5-B0B2-467B-85F2-F6265DA0FA2BQ37866754-F7F48CEE-021C-4933-8BD9-DCFA18CA6269Q37944318-38004A0B-6664-4C43-B1FF-767E7B4CB0C4Q37959559-08C69269-AFEF-4C70-880A-C05BB2295E69Q38046665-F7325BAF-9F0D-4B80-944D-F93B188CD2C9Q40840632-350CA212-6E6E-4FAF-8510-6C9A2CFA225BQ42269528-10C2BEF3-1DB7-4E91-8DA8-B2A61B1951C4Q44957451-C5D70A4A-F591-4567-96B7-D43474B4D00FQ46077494-CB508F6D-D8A8-4EA1-A5CF-DF2494EDF59FQ47323773-A8F8D5B8-71F9-456B-9D89-FF383DEF7607Q53514447-254436DD-8F39-4CC4-8F8E-E5CCD08DF360
P2860
Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine
description
im März 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2009
@uk
name
Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine
@en
Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine
@nl
type
label
Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine
@en
Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine
@nl
prefLabel
Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine
@en
Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine
@nl
P356
P1433
P1476
Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine
@en
P304
P356
10.1542/PEDS.2009-0466
P407
P577
2009-03-30T00:00:00Z